Aspergillus Fumigatus

Mechanism-of-action class: Antibody-Receptor Interactions.

• USES: May help temporarily relieve allergy symptoms ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.ICD-10: R51.9

DIRECTIONS: Adults and children 12 years and over: ■ take 15 drops under the tongue every 3-4 hours ■ sensitive persons and asthma sufferers take 1-3 drops and wait 3 hours then continue with regular dosage provided ■ if allergy or asthma symptoms develop, discontinue use

Stop use and ask a doctor if ■ symptoms do not improve in 5 days or new symptoms appear ■ you are an asthma sufferer with severe mold allergies If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is missing or open. ■ Store tightly closed at room temperature (65-80ºF)

Recent PubMed references pinned to Aspergillus Fumigatus as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• The therapeutic effect of 5-nitro-8-hydroxyquinoline on Aspergillus fumigatus: results from in vitro and in vivo models of invasive aspergillosis.
  Frontiers in cellular and infection microbiology · 2026 · Ran J, Zhou X, Gao Z, et al.
  PMID 42272757DOI 10.3389/fcimb.2026.1843404
• Managing Azole Resistance in Aspergillus.
  Medical mycology journal · 2026 · Kushima H, Ishii H
  PMID 42219345DOI 10.3314/mmj.26.008
• Prevalence and Clinical Implications of Aspergillus fumigatus Sensitisation in Chronic Obstructive Pulmonary Disease.
  Mycoses · 2026 · Luo Y, Sun Y
  PMID 42175684DOI 10.1111/myc.70185
• Immune interaction between Aspergillus fumigatus and non-tuberculous mycobacteria.
  Frontiers in cellular and infection microbiology · 2026 · Namie H, Takazono T, Irifune S, et al.
  PMID 42157996DOI 10.3389/fcimb.2026.1810773
• Neutrophil extracellular traps are found at epithelial barriers in canine sinonasal aspergillosis.
  Frontiers in immunology · 2026 · Janssen P, de Meeûs C, Garigliany MM, et al.
  PMID 42148123DOI 10.3389/fimmu.2026.1808191
• Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in Aspergillus spp.? Comparative analysis with CLSI broth microdilution and cyp51A gene sequencing.
  Antimicrobial agents and chemotherapy · 2026 · Vahedi-Shahandashti R, Nickel A-S, Eisele D, et al.
  PMID 42138696DOI 10.1128/aac.01813-25
• Follow up of a previous aspergillosis case report treated with oxygen-ozone therapy, reporting clinical remission of the lung fungal infection.
  International immunopharmacology · 2026 · Franzini M, Valdenassi L, Chirumbolo S, et al.
  PMID 42127494DOI 10.1016/j.intimp.2026.116831
• Aspergillus fumigatus Gliotoxin Inhibits LC3-Associated Phagocytosis in Macrophages in a Calcium-Dependent Manner.
  Journal of immunology research · 2026 · Sun Y, Chen F, Zhang L, et al.
  PMID 42057339DOI 10.1155/jimr/5542735

The 10 most recently updated of 14 ClinicalTrials.gov registrations naming Aspergillus Fumigatus as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
  Recruiting · Observational · 100 enrolled · University Hospital, Strasbourg, France
  NCT07313527updated 2026-01-02
• Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis
  Completed · Observational · 350 enrolled · Assistance Publique - Hôpitaux de Paris
  NCT03349931updated 2025-11-20
• Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)
  Completed · Observational · 67 enrolled · University Hospital, Rouen
  NCT07055230updated 2025-07-08
• A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®
  Recruiting · Phase 2 · Interventional · 30 enrolled · University Hospital, Basel, Switzerland
  NCT02007356updated 2025-03-20
• T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation
  Completed · Phase 1 · Phase 2 · Interventional · 10 enrolled · George Papanicolaou Hospital
  NCT05471661updated 2024-12-27
• Immune Profiles in CF Fungal Infection
  Completed · Observational · 24 enrolled · University of Alabama at Birmingham
  NCT04476758updated 2024-07-18
• Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy
  Completed · Observational · 203 enrolled · University Hospital of Cologne
  NCT03221075updated 2023-05-12
• The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic Fibrosis
  Terminated · Phase 2 · Interventional · 4 enrolled · Pulmocide Ltd
  NCT03870841updated 2021-07-16
• The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.
  Terminated · Phase 2 · Interventional · 2 enrolled · Pulmocide Ltd
  NCT03905447updated 2021-07-16
• THYME AND CARVACROLL Nanoparticle Effect on Fungi
  Completed · Observational · 210 enrolled · Assiut University
  NCT04431804updated 2020-11-05

Frequently asked questions

How does Aspergillus Fumigatus work?

Mechanism-of-action class: Antibody-Receptor Interactions.

What is Aspergillus Fumigatus used for?

According to FDA labeling, Aspergillus Fumigatus carries indications including: USES: May help temporarily relieve allergy symptoms ■ congestion ■ headache ■ itchy, watery eyes ■ sneezing *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.

What class of drug is Aspergillus Fumigatus?

Aspergillus Fumigatus is classified as Antibody-Receptor Interactions, Cell-mediated Immunity, Increased Cellular Migration, Increased Histamine Production, Increased Histamine Release, Increased IgG Production, Increased T Lymphocyte Activation.